NCT03281486View on ClinicalTrials.gov

"Hyaluronan Formulation for Type 2 Diabetic Patients With Dry Mouth"

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 28, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

December 31, 2019

Conditions
Dry MouthXerostomiaType 2 Diabetics
Interventions
DEVICE

HA formulation Oral Spray

It is an HA formulation of FDA listed ingredients

DEVICE

Placebo

Placebo formulation without the active ingredients

Trial Locations (1)

63104

Division of Endocrinology and Metabolism, Saint Louis University, St Louis

All Listed Sponsors
lead

You First Services

INDUSTRY

NCT03281486 - "Hyaluronan Formulation for Type 2 Diabetic Patients With Dry Mouth" | Biotech Hunter | Biotech Hunter